Clinical Trial

BOne Metastases REgistry for Patients Undergoing cryoAbLation With curatIve purpoSe

Study acronym: BOREALIS
Recruiting
View on ClinicalTrials.gov →
Summary
BOREALIS is a multicentre, prospective, observational cohort study designed to investigate the effectiveness, feasibility, safety and impact on pain and quality of life of curative-intent cryoablation for the treatment of bone metastases in patients with oligometastatic or bone oligo-progressive disease.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-06-25.
Status change: Not Yet Recruiting → Recruiting 2025-12-23
Trial Details
NCT Number NCT06480955
Lead Sponsor Cardiovascular and Interventional Radiological Society of Europe
Collaborators: Boston Scientific Corporation
Conditions Bone Metastases
Enrollment 50 participants
Start Date 2025-04-01
Primary Completion 2027-04 (estimated)
Study Completion 2028-04 (estimated)
Updated on ClinicalTrials.gov 2025-12-30